BPA Call 36C24126A0041-36C24126N0799
Award Date 9/21/26
Potential Completion Date 9/20/27
Potential Value $659K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Not listed Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rosemont, IL 60018, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Veterans Integrated Service Network 2 (a civilian subdivision of the Department of Veterans Affairs) issued a BPA call to Abbott Molecular Inc. valued at $1,481,076.97, with an award date of May 15, 2026 and ultimate completion date of May 14, 2027. The call is placed against a $12.5 million single-award Blanket Purchase Agreement for Alinity M reagents. Place of performance is Rosemont, Illinois. The call is priced on a firm fixed price basis and procures Alinity M molecular diagnostic reagents...
- Veterans Integrated Service Network 6 issued a BPA call to Abbott Molecular Inc. for Alinity reagents, controls, and consumables, with a ceiling value of $421,177.66 and an award date of May 1, 2026. The call is issued under the In-Vitro Diagnostics, Reagents, Test (FSS-65-VII) GSA Schedule. Performance takes place in Rosemont, Illinois, with an ultimate completion date of April 30, 2027. The call is firm fixed price and covers molecular diagnostic consumables supporting infectious disease...
- Veterans Integrated Service Network 6 issued a BPA call to Abbott Molecular Inc. for Alinity reagents, controls, and consumables with a ceiling value of $235,162.32, effective May 1, 2025. The call is issued under the Invitro Diagnostics, Reagents, Test (FSS-65-VII) GSA Schedule. Performance occurs in Rosemont, Illinois, with ultimate completion targeted for April 30, 2026. Abbott Molecular is a large for-profit manufacturer of in-vitro diagnostic substances and laboratory instrumentation with...
- Veterans Integrated Service Network 8 issued a BPA call to Abbott Laboratories Inc. on June 30, 2026, for Alinity M SARS-CoV-2/HIV reagents with a ceiling value of $965,388.38. The call is placed under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule. Work is performed in Rosemont, Illinois. The period of performance extends through June 29, 2027. The call procures reagent supplies for the Alinity M analyzer platform to support infectious disease testing capabilities across VISN 8...
- Veterans Integrated Service Network 8 issued a BPA call to Abbott Laboratories Inc. on June 30, 2024, for Alinity M SARS-CoV-2/HIV reagents, with a ceiling value of $737,306.30 and an ultimate completion date of June 29, 2025. The call is placed under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule. Performance occurs in Rosemont, Illinois. The call is priced on a firm fixed-price basis and procures diagnostic reagents supporting SARS-CoV-2 and HIV testing capabilities on Abbott's...
- Abbott Molecular Inc., a subsidiary of Abbott Laboratories, received a Blanket Purchase Agreement (BPA) call order valued at $2.76 million from Veterans Integrated Service Network 19 for Alinity M reagents and supplies. The contract, awarded on December 1, 2023, with completion targeted for November 30, 2024, operates under the General Services Administration's In-Vitro Diagnostics, Reagents, Test (FSS-65-VII) schedule and utilizes firm fixed pricing. The supplies will be delivered to the...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded a $946,164.89 firm-fixed-price blanket purchase agreement call contract to Abbott Molecular Inc., a division of Abbott Laboratories, to deliver ALINITY-M reagent kits and consumables. Performance will take place in Des Plaines, Illinois over one base year, from October 1, 2021 through September 30, 2022. The contract calls for molecular diagnostics products to support the VA's...
- Abbott Molecular Inc., a subsidiary of Abbott Laboratories, has been awarded a $550,000 Blanket Purchase Agreement (BPA) call for Alinity M reagents and supplies by Veterans Integrated Service Network (VISN) 19, effective through November 30, 2025. The contract utilizes firm fixed pricing and is issued under the parent GSA Schedule vehicle for In-Vitro Diagnostics, Reagents, and Test (FSS-65-VII). Performance will be conducted at Abbott Molecular's facility in Aurora, Colorado. This award...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 (VA - VHA) awarded a $769,130.07 delivery order contract to Abbott Molecular Inc. Abbott Molecular Inc. Division for ABBOTT ALINITY REAGENTS AND SUPPLIES indefinite-delivery, indefinite-quantity (IDIQ) from October 1, 2022 through September 30, 2023. The firm fixed price contract will provide reagents and supplies from Abbott Molecular Inc.'s Alinity line of products to support laboratory...
- <p>Veterans Integrated Service Network 7 issued a delivery order to Abbott Molecular Inc. on April 1, 2022, for an Alinity M chemistry analyzer with a ceiling value of $1,639,116.43, under the GSA Schedule In-Vitro Diagnostics, Reagents, Test (FSS-65-VII).</p> <p>Place of performance is Rosemont, IL. The order is firm fixed price with an ultimate completion date of March 31, 2027. No set-aside applies.</p>
Veterans Integrated Service Network 1 issued a BPA call to Abbott Molecular Inc. for Alinity M reagents and supplies with a ceiling value of $658,749.82, awarded September 21, 2026, with performance completion by September 20, 2027. Place of performance is Rosemont, Illinois. The call is priced firm fixed price and covers molecular diagnostic reagents and consumables for the Alinity M platform supporting VISN 1 laboratory testing operations.
Generated 8/3/26, 10:02 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $658.7k | 8/1/26 |